Cetera Trust Company, N.A Bristol Myers Squibb CO Transaction History
Cetera Trust Company, N.A
- $159 Billion
- Q2 2024
A detailed history of Cetera Trust Company, N.A transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cetera Trust Company, N.A holds 17,927 shares of BMY stock, worth $967,340. This represents 0.47% of its overall portfolio holdings.
Number of Shares
17,927
Previous 20,092
10.78%
Holding current value
$967,340
Previous $1.09 Billion
31.67%
% of portfolio
0.47%
Previous 0.66%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,404Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.56 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.93 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.03 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.19 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...